Study design and baseline characteristics of patients in the PRESENT study

Diabetes Research and Clinical Practice

Volumn 81, Issue SUPPL.1, 2008, Pages

  Shestakova, Marina ^a   Bech, Ole Molskov ^b   Momani, Munther S ^c  

^a Institute of Diabetes   (Russian Federation)

^b SIBS Novo Nordisk Translational Research Centre for PreDiabetes   (China)

^c Al Habib Medical Centre ^*  (Saudi Arabia)

Author keywords

Biphasic insulin aspart 30; Glycaemic control; Hypoglycaemia; Observational study

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C; HUMAN INSULIN; INSULIN; INSULIN ASPART; INSULIN DERIVATIVE; ORAL ANTIDIABETIC AGENT;

ADULT; CLINICAL TRIAL; DECISION MAKING; DIABETIC NEPHROPATHY; DIABETIC NEUROPATHY; DIABETIC RETINOPATHY; DISEASE CONTROL; DISEASE DURATION; FEMALE; FOOT DISEASE; GLUCOSE BLOOD LEVEL; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; HYPOGLYCEMIA; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; METHODOLOGY; NON INSULIN DEPENDENT DIABETES MELLITUS; REVIEW; STROKE;

CLINICAL TRIALS AS TOPIC; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; HYPOGLYCEMIA; HYPOGLYCEMIC AGENTS; INSULIN; MALE; MIDDLE AGED; MULTICENTER STUDIES AS TOPIC; PATIENT SELECTION; RESEARCH DESIGN;

EID: 48949100750     PISSN: 01688227     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.diabres.2008.06.008     Document Type: Review

References (19)

1. UKPDS Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 352 (1998) 837-853
2. American Diabetes Association. Implications of the United Kingdom prospective diabetes study. Diab. Care Suppl. 126 (2003) S28-S32
3. El-Kebbi I.M., Ziemer D.C., Cook C.B., Gallima D.L., Barnes C.S., and Phillips L.S. Utility of casual postprandial glucose levels in type 2 diabetes management. Diab. Care 27 (2004) 335-339
4. Monnier L., Lapinski H., and Colette C. Contributions of fasting and postprandial plasma glucose increments to the overall diurnal hyperglycemia of type 2 diabetic patients. Diab. Care 26 (2003) 881-885
5. DECODE, Study Group the European Diabetes Epidemiology Group. Glucose tolerance and cardiovascular mortality: comparison of fasting and 2-hour diagnostic criteria. Arch. Intern. Med. 161 (2001) 397-405
6. Selvin E., Marinopoulos S., Berkenblit G., Rami T., Brancati F.L., and Powe N.P. Meta-analysis: glycosylated hemoglobin and cardiovascular disease in diabetes mellitus. Ann. Intern. Med. 141 (2004) 421-431
7. Qiao Q., Tuomilehto J., and Borch-Johnsen K. Post-challenge hyperglycaemia is associated with premature death and macrovascular complications. Diabetologia 46 Suppl. 1 (2003) M17-M21
8. International Diabetes Federation, Clinical Guidelines Task Force. Global guideline for type 2 diabetes. Available from http://www.idf.org/home/index.cfm?unode=B7462CCB-3A4C-472C-80E4-710074D7 4AD3. Accessed January 21, 2008.
9. Weyer C., Heinemann L., and Heise T. Insulin aspart in a 30/70 premixed formulation: pharmacodynamic properties of a rapid acting insulin analog in stable mixture. Diabetes 20 (1997) 1612-1614
10. McSorley P.T., Bell P.M., Jacobsen L.V., Kristensen A., and Lindholm A. Twice-daily biphasic insulin aspart 30 versus biphasic human insulin 30: a double-blind crossover study in adults with type 2 diabetes mellitus. Clin. Ther. 24 (2002) 530-539
11. Garber A.J., Ligthelm R., Christiansen J.S., and Liebl A. Premixed insulin treatment for type 2 diabetes: analogue or human?. Diab. Obes. Metab. 9 (2007) 630-639
12. Kapitza C., Rave K., Ostrowski K., Heise T., and Heinemann L. Reduced postprandial glycaemic excursion with biphasic insulin Aspart 30 injected immediately before a meal. Diab. Med. 21 (2004) 500-501
13. Lindholm A., Jacobsen L.V., Bell P.M., McSorley P.T., and Kristensen A. Improved postprandial glucose control with biphasic insulin aspart 30 in Type 2 diabetes. Diab. Med. 18 Suppl. 2 (2001) 83 Abstract P160
14. Gough S. Post-marketing surveillance: a UK/European perspective. Curr. Med. Res. Opin. 21 (2005) 565-570
15. Ligthelm R.J., Borzi V., Gumprecht J., Kawamori R., Wenying Y., and Valensi P. Importance of observational studies in clinical practice. Clin. Ther. 29 (2007) 1284-1292
16. Stratton I.M., Adler A.I., Neil H.A., Matthews D.R., Manley S.E., Cull C.A., et al. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. BMJ 321 (2000) 405-412
17. Lee I., Lee S.R., Lebedev N., Kedijang T., Tuna S., Hassan A., et al. Biphasic insulin aspart 30 improves treatment results in patients with early type 2 diabetes with early type 2 diabetes poorly controlled on prior diabetes treatment: preliminary results from the PRESENT Study. Diabetes 56 Suppl. 1 (2007) A567
18. American Association of Clinical Endocrinologists. Medical guidelines for the management of diabetes mellitus: the AACE system of intensive diabetes self-management-2002 update. Endocr. Pract. 8 Suppl. 1 (2002) 40-83
19. American Association of Clinical Endocrinologists (AACE) Diabetes Guidelines. Available at: http://www.aace.com/clin/guidelines/diabetes_2002.pdf. Accessed January 21, 2008.